-
Most Recent
Search Results
240 results for bmti
Bank on This Pair of Biotech Bargains
When it comes to small biotechs, one successful product can send its stock soaring. This pair of companies currently have promising treatments on the horizon.
4 Biotechnology Stocks to Buy Now
This week, four Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Bebe, Apac and JVA Stock All Reach 52-Week Highs
Stocks setting 52-week highs include Apac Customer Service NASDAQ:APAC), Bebe Stores NASDAQ:BEBE, and Coffee Holding Co NASDAQ:JVA.
7 Biotechnology Stocks to Buy Now
Seven Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
BioMimetic Has Suitors Lying in Wait
A key FDA OK could have the buyout offers rolling in.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a…
Palomar Medical Technologies (PMTI) Reinventing the Fountain of Youth
Remember that song by Carly Simon, “You’re So Vain?” I heard it on the radio the other day and thought it would be good song…
Wall Street Loves to Make Predictions — but This Trader Does Something Else
In today’s guest essay, veteran trader Jonathan Rose explains why he focuses less on predicting the future and more on tracking where institutional money and…
When Volatility and Money Flow Point to the Same Stock
Smart money trading focuses on evidence, not forecasts. Ameresco is flashing signals tied to AI power and grid modernization.
BITI ETF: 10 Things to Know About the New ProShares Short Bitcoin ETF
Investors wondering how to short Bitcoin (BTC) are gaining a new option with the ProShares Short Bitcoin Strategy ETF (BITI).
Bristol-Myers Squibb Co’s (BMY) Solid Quant Score Keeps it a Buy
The current recommendation of Buy for Bristol-Myers Squibb Co (NYSE:BMY) is derived using Louis Navellier’s approach to investing and his Portfolio Grader stock evaluator. BMY…
Should I Buy Bristol-Myers Squibb? 3 Pros, 3 Cons
Its deal to buy diabetes-drug maker Amylin will help, given that market’s potential. Still, patent expirations loom large and won’t be easily overcome.
Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings Visibility
Bristol-Myers Squibb Co (NYSE:BMY) is a constituent of the 135 company Pharmaceuticals GICS industry group, which is part of the 783 company GICS Health Care…
Bristol-Myers Squibb Co (BMY) Industry Group Rank Penalize Rating
Bristol-Myers Squibb Co (NYSE:BMY) is a $103.5 billion in market value constituent of the Pharmaceuticals GICS industry group where Portfolio Grader’s current ranking for BMY…
British American Tobacco (BTI) a Buy on Solid Quant Score
British American Tobacco Plc (NYSE:BTI) is a $66.3 billion in market value component of the Tobacco GICS industry group where currently BTI is ranked 1…
1 – 10 of 240 results
